DNTHDianthus Therapeutics, Inc.

$110.57

Who owns DNTH

240 institutions reported holding DNTH for 2026Q1, together 129% of the company, more than the 166 a quarter earlier.

240

Institutions reporting a position · as of 2026Q1 · up from 166 the quarter before

Shares held by institutions
62.1M

Shares held by institutions · 129% of the company · long US equity positions only, as reported on Form 13F

Reported value
$5.18B

Reported value · at 2026-03-31 prices, not today's

Opened vs closed
91 / 22

Opened vs closed · new positions against positions exited in the latest quarter

Details
Reporting quarter2026-03-31
2026Q1
Quarters on record
11
New positions
91
Positions exited
22
Added to
82
Reduced
53
Institutional ownership by quarter, 2023Q3 to 2026Q1
QuarterFilersSharesReported value
2026Q124062.1M$5.18B
2025Q416649.1M$2.02B
2025Q314046.8M$1.84B
2025Q210239.1M$729M
2025Q19837.7M$685M
2024Q49535.1M$766M
2024Q39131.4M$859M
2024Q27429.7M$769M
2024Q17626.1M$782M
2023Q43910.3M$107M
2023Q33010.1M$136M
Largest reported holders, 2026Q1
HolderShares% of companyValue
FMR LLC7.8Mn/a$652M
BlackRock Inc.3.2Mn/a$267M
VANGUARD GROUP INC2.7Mn/a$225M
RA CAPITAL MANAGEMENT, L.P.2.6Mn/a$219M
WELLINGTON MANAGEMENT GROUP LLP2.6Mn/a$218M
Fairmount Funds Management LLC2.5Mn/a$213M
Avidity Partners Management LP2.1Mn/a$185M
Octagon Capital Advisors LP1.9Mn/a$163M
TCG Crossover Management, LLC1.7Mn/a$141M
CITADEL ADVISORS LLC1.6Mn/a$135M

SEC Form 13F data sets (DERA bulk files). 13F is quarterly, filed up to 45 days late, and covers long US equity positions only, no shorts, no derivatives, nothing held below the reporting threshold.

reading the register…